Active, Not Recruiting
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
NCT04668300
- Conditions
- Hemangiosarcoma, Liposarcoma, Metastatic Angiosarcoma, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States